Use of s-triazines for treating apicomplexan parasitic...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/53 (2006.01) A61K 45/06 (2006.01) A61P 33/02 (2006.01) A61P 33/06 (2006.01)

Patent

CA 2359678

This invention relates to novel compositions and methods of treating humans and animals infected by Apicomplexan parasites. More specifically, the present invention relates to treating an Apicomplexan infection by administering s- triazines, such as atrazine, to an infected human or animal. The present invention also relates to pharmaceutical compositions containing therapeutically effective amounts of s-triazines, such as atrazine, useful in treating parasitic infections.

L'invention concerne de nouvelles compositions et techniques permettant de traiter des animaux et des humains infectés par des parasites Apicomplexan. L'invention concerne, plus spécifiquement, le traitement d'une infection provoquée par un parasite Apicomplexan par administration de s-triazines, telles que l'atrazine, à un animal ou un humain infecté. L'invention concerne également des compositions pharmaceutiques renfermant des quantités thérapeutiquement efficaces de s-triazines, telles que l'atrazine, utiles pour traiter des infections parasitaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of s-triazines for treating apicomplexan parasitic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of s-triazines for treating apicomplexan parasitic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of s-triazines for treating apicomplexan parasitic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1555159

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.